Strain dependence of the cell wall-damage induced stimulon in Staphylococcus aureus

Biochimica et Biophysica Acta - General Subjects

Volumn 1760, Issue 10, 2006, Pages 1475-1481

  McCallum, N ^a   Spehar, G ^a   Bischoff, M ^a   Berger Bachi B ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Cell wall stress stimulon; Glycopeptide intermediate resistance; S. aureus

Indexed keywords

TRANSCRIPTOME; VANCOMYCIN;

ARTICLE; BACTERIAL CELL WALL; CELL DAMAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE INDUCTION; GENE LOCUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; STIMULON; STRAIN DIFFERENCE;

BACTERIAL PROTEINS; CELL WALL; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION PROFILING; GENES, BACTERIAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SPECIES SPECIFICITY; STAPHYLOCOCCUS AUREUS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

STAPHYLOCOCCUS AUREUS;

EID: 33748884394     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2006.06.008     Document Type: Article

References (28)

1. Giesbrecht P., Kersten T., Maidhof H., and Wecke J. Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin. Microbiol. Mol. Biol. Rev. 62 (1998) 1371-1414
2. Utaida S., Dunman P.M., Macapagal D., Murphy E., Projan S.J., Singh V.K., Jayaswal R.K., and Wilkinson B.J. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. Microbiology 149 (2003) 2719-2732
3. Singh V.K., Jayaswal R.K., and Wilkinson B.J. Cell wall-active antibiotic induced proteins of Staphylococcus aureus identified using a proteomic approach. FEMS Microbiol. Lett. 199 (2001) 79-84
4. McAleese F., Wu S.W., Sieradzki K., Dunman P., Murphy E., Projan S., and Tomasz A. Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate-S. aureus-type resistance to vancomycin. J. Bacteriol. 188 (2006) 1120-1133
5. Berger-Bächi B., and Rohrer S. Factors influencing methicillin resistance in staphylococci. Arch. Microbiol. 178 (2002) 165-171
6. Courvalin P. Vancomycin resistance in gram-positive cocci. Clin. Infect. Dis. 42 (2006) S25-S34
7. Sieradzki K., and Tomasz A. Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus. J. Bacteriol. 185 (2003) 7103-7110
8. Bischoff M., Roos M., Putnik J., Wada A., Glanzmann P., Giachino P., Vaudaux P., and Berger-Bächi B. Involvement of multiple genetic loci in Staphylococcus aureus teicoplanin resistance. FEMS Microbiol. Lett. 194 (2001) 77-82
9. Hiramatsu K. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect. Dis. 1 (2001) 147-155
10. Cui L., Ma X.X., Sato K., Okuma K., Tenover F.C., Mamizuka E.M., Gemmell C.G., Kim M.N., Ploy M.C., El Solh N., Ferraz V., and Hiramatsu K. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J. Clin. Microbiol. 41 (2003) 5-14
11. Cui L., Iwamoto A., Lian J.Q., Neoh H.M., Maruyama T., Horikawa Y., and Hiramatsu K. Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 50 (2006) 428-438
12. Bischoff M., and Berger-Bächi B. Teicoplanin stress-selected mutations increasing sigma(B) activity in Staphylococcus aureus. Antimicrob. Agents Chemother. 45 (2001) 1714-1720
13. Sakoulas G., Eliopoulos G.M., Fowler V.G.J., Moellering R.C.J., Novick R.P., Lucindo N., Yeaman M.R., and Bayer A.S. Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function. Antimicrob. Agents Chemother. 49 (2005) 2687-2692
14. Kuroda M., Kuroda H., Oshima T., Takeuchi F., Mori H., and Hiramatsu K. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol. Microbiol. 49 (2003) 807-821
15. Komatsuzawa H., Fujiwara T., Nishi H., Yamada S., Ohara M., McCallum N., Berger-Bächi B., and Sugai M. The gate controlling cell wall synthesis in Staphylococcus aureus. Mol. Microbiol. 53 (2004) 1221-1231
16. Mongodin E., Finan J., Climo M.W., Rosato A., Gill S., and Archer G.L. Microarray transcription analysis of clinical Staphylococcus aureus isolates resistant to vancomycin. J. Bacteriol. 185 (2003) 4638-4643
17. Kuroda M., Kuwahara-Arai K., and Hiramatsu K. Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method. Biochem. Biophys. Res. Commun. 269 (2000) 485-490
18. Cui L., Lian J.Q., Neoh H.M., Reyes E., and Hiramatsu K. DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 49 (2005) 3404-3413
19. Boyle-Vavra S., Yin S.H., Challapalli M., and Daum R.S. Transcriptional induction of the penicillin-binding protein 2 gene in Staphylococcus aureus by cell wall-active antibiotics oxacillin and vancomycin. Antimicrob. Agents Chemother. 47 (2003) 1776
20. Sieradzki K., Pinho M.G., and Tomasz A. Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus. J. Biol. Chem. 274 (1999) 18942-18946
21. Nishi H., Komatsuzawa H., Fujiwara T., McCallum N., and Sugai M. Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in Staphylococcus aureus. Antimicrob. Agents Chemother. 48 (2004) 4800-4807
22. Ruzin A., Severin A., Moghazeh S.L., Etienne J., Bradford P.A., Projan S.J., and Shlaes D.M. Inactivation of mprF affects vancomycin susceptibility in Staphylococcus aureus. Biochim. Biophys. Acta 1621 (2003) 117-121
23. Maki H., McCallum N., Bischoff M., Wada A., and Berger-Bächi B. TcaA inactivation increases glycopeptide resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 48 (2004) 1953-1959
24. Duthie E.S., and Lorenz L.L. Staphylococcal coagulase: mode of action and antigenicity. J. Gen. Microbiol. 6 (1952) 95-107
25. Bischoff M., Dunman P., Kormanec J., Macapagal D., Murphy E., Mounts W., Berger-Bächi B., and Projan S. Microarray-based analysis of the Staphylococcus aureus sigmaB regulon. J. Bacteriol. 186 (2004) 4085-4099
26. Kreiswirth B.N., Lofdahl S., Betley M.J., O'Reilly M., Schlievert P.M., Bergdoll M.S., and Novick R.P. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305 (1983) 709-712
27. Wootton M., Macgowan A.P., and Walsh T.R. Expression of tcaA and mprF and glycopeptide resistance in clinical glycopeptide-intermediate Staphylococcus aureus (GISA) and heteroGISA strains. Biochim. Biophys. Acta 1726 (2005) 326-327
28. Katayama Y., Zhang H.Z., and Chambers H.F. PBP 2a mutations producing very-high-level resistance to beta-lactams. Antimicrob. Agents Chemother. 48 (2004) 453-459